US Broker Ratings

Supernus Pharmaceuticals, Inc. (SUPN) Stock Analysis: Navigating a 6.52% Potential Upside in the CNS Market

Supernus Pharmaceuticals, Inc. (SUPN), a key player in the healthcare sector specializing in the development and commercialization of treatments for central nervous system (CNS) disorders, offers..

CONMED Corporation (CNMD) Stock Analysis: A Medical Device Player with 35.98% Potential Upside

CONMED Corporation (NASDAQ: CNMD), a prominent player in the healthcare sector specializing in medical devices, presents a compelling investment opportunity for those interested in the medical..

Twist Bioscience Corporation (TWST) Stock Analysis: Navigating the DNA Frontier with a 24.89% Upside

Twist Bioscience Corporation (NASDAQ: TWST) is at the forefront of the synthetic biology revolution, leveraging its expertise in synthetic DNA-based products to transform the healthcare and..

MannKind Corporation (MNKD): Investor Outlook and 89.32% Potential Upside in Biotech

MannKind Corporation (NASDAQ: MNKD), a notable player in the biotechnology landscape, is making waves with its innovative solutions in the healthcare sector. Specializing in therapeutic products..

Select Medical Holdings Corp (SEM): Investor Outlook on a 35% Potential Upside with Strong Buy Ratings

As investors scour the healthcare sector for promising opportunities, Select Medical Holdings Corporation (NYSE: SEM) emerges as an intriguing candidate. With a market capitalization of $1.66..

ARS Pharmaceuticals (SPRY) Stock Analysis: Unpacking the Massive 263% Upside Potential

Investors eyeing the biotechnology sector might want to take a closer look at ARS Pharmaceuticals, Inc. (NASDAQ: SPRY), a company making significant strides in the healthcare..

Guardian Pharmacy Services, Inc. (GRDN): Investor Outlook with a 14.8% Revenue Growth Trajectory

Guardian Pharmacy Services, Inc. (NASDAQ: GRDN), a significant player in the healthcare sector, specializes in providing technology-enabled pharmacy services to long-term healthcare facilities across the United..

Phreesia, Inc. (PHR): Investor Outlook Highlights 48.7% Potential Upside

Phreesia, Inc. (NYSE: PHR), a leader in healthcare information services, is capturing investor attention with a promising potential upside of 48.7%. Specializing in a SaaS-based platform,..

Schrodinger, Inc. (SDGR) Investor Outlook: Analyzing a 31% Potential Upside in Health Information Services

Schrodinger, Inc. (NASDAQ: SDGR) is making waves in the healthcare sector with its innovative approach to drug development and molecular discovery. With a market capitalization of..

Pulse Biosciences, Inc (PLSE) Stock Analysis: Is a 31% Upside Within Reach for This Bioelectric Medicine Pioneer?

Pulse Biosciences, Inc. (NASDAQ: PLSE), a trailblazer in the field of bioelectric medicine, is making waves in the healthcare sector with its cutting-edge technology and innovative..

ANI Pharmaceuticals, Inc. (ANIP) Stock Analysis: A 13.76% Potential Upside Awaits Investors

ANI Pharmaceuticals, Inc. (NASDAQ: ANIP) stands out in the healthcare sector, especially within the niche of specialty and generic drug manufacturing. The company, headquartered in Baudette,..

Apellis Pharmaceuticals, Inc. (APLS) Stock Analysis: A 76% Upside with Strong Buy Ratings in the Biotech Arena

For investors exploring opportunities within the healthcare sector, particularly in biotechnology, Apellis Pharmaceuticals, Inc. (NASDAQ: APLS) presents a compelling case. With a market capitalization standing at..

Liquidia Corporation (LQDA) Stock Analysis: A Biotech Marvel with 48% Upside Potential

For investors with a keen eye on the biotechnology sector, Liquidia Corporation (NASDAQ: LQDA) presents an intriguing opportunity. The biopharmaceutical company, headquartered in Morrisville, North Carolina,..

Indivior PLC (INDV) Stock Analysis: Healthcare Innovator with 17.67% Upside Potential

Indivior PLC (INDV) is making waves in the healthcare sector, particularly within the niche of drug manufacturing focused on specialty and generic medications. With its market..

CG Oncology, Inc. (CGON) Stock Analysis: A Promising 62.49% Upside in the Biotech Arena

CG Oncology, Inc. (NASDAQ: CGON) is capturing the attention of investors with its significant potential upside of 62.49%, according to recent analyst ratings. This late-stage clinical..

GoodRx Holdings, Inc. (GDRX) Stock Analysis: Exploring a 62.71% Potential Upside for Investors

GoodRx Holdings, Inc. (NASDAQ: GDRX) is drawing attention in the healthcare sector with its innovative approach to prescription savings and a substantial potential upside of 62.71%,..

Centessa Pharmaceuticals plc (CNTA) Stock Analysis: A Promising 38.81% Upside in the Biotech Sector

Centessa Pharmaceuticals plc (NASDAQ: CNTA), a dynamic player in the biotechnology industry, is capturing investor attention with its robust growth potential and a compelling 38.81% upside..

Progyny, Inc. (PGNY) Investor Outlook: Exploring a 53% Potential Upside in the Fertility Benefits Sector

Progyny, Inc. (PGNY), a key player in the healthcare plans industry, is drawing considerable attention from investors, and for good reason. With a market capitalization of..

Structure Therapeutics Inc. (GPCR) Stock Analysis: Unraveling a 123% Upside Potential in the Biotech Sector

Structure Therapeutics Inc. (NASDAQ: GPCR) is capturing the attention of investors with its impressive potential upside of 123.49%. Operating in the dynamic biotechnology sector, this clinical-stage..

SS Innovations International (SSII): A Healthcare Player with Robust Revenue Growth but Lingering Profitability Challenges

SS Innovations International, Inc. (SSII), a prominent player in the medical devices sector, is making waves with its expansive portfolio of surgical robotics and cutting-edge medical..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds